Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

Mast cells infiltrates are common in eosinophilic esophagitis and still elevated in histological remission: A digital evaluation in children (2025) Hironimus T, Degen S, Rappl A, Allabauer I, Wölfle J, Hartmann A, Bruns V, et al. Journal article Tumor clusters with divergent inflammation and human retroelement expression determine the clinical outcome of patients with serous ovarian cancer (2025) Gloßner L, Eckstein M, Mark C, Beckmann M, Hartmann A, Strissel P, Strick R Journal article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article Interobserver reproducibility of a hybrid three-tier grading system of papillary nonmuscle invasive urothelial carcinoma: an international Uropathology study (2025) Downes MR, Lajkosz K, Algaba F, Allory Y, Amin MB, Cheng L, Desai S, et al. Journal article Pathologically Tumor-free Resection Margin Distance as a Surrogate Parameter in Primary Vulvar Squamous Cell Cancer: Analysis of a Large Two-Center Patient Cohort (2025) Balog E, Stübs F, Berndt R, Dietl A, Geppert CI, Hartmann A, Thunich O, et al. Journal article Malignant upgrade in lesions of uncertain malignant potential in the breast (B3 lesions) – is open excision always necessary? (2025) Heindl F, Schiel J, Hack C, Amann N, Jud S, Preuss CI, Häberle L, et al. Journal article Perioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit (2025) Jing S, Song J Journal article, Letter Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers. (2025) Häberle L, Erber R, Gaß P, Hein A, Niklos M, Volz B, Hack C, et al. Journal article Histomorphologisch definierte Nierenzellkarzinome 2025: Aktuelle WHO-Klassifikation und sich abzeichnende zukünftige Subtypen (2025) Stöhr C, Fiegl A, Bercebal C, Agaimy A, Hartmann A Journal article, Review article Molekular definierte Nierenzellkarzinome 2025 (2025) Stöhr C, Fiegl A, Bercebal C, Agaimy A, Hartmann A Journal article, Review article